Plaque Psoriasis Trial for Teens (66 Weeks)

Adolescents aged 12 to under 18 years old with stable plaque psoriasis for 6 months or more, may qualify to participate. Individuals must have moderate to severe plaque psoriasis and be able to swallow study medication. Teens with a medical history of JPsA (juvenile psoriatic arthritis) or who report symptoms suggestive of JPsA at screening, must have a confirmed diagnosis.

This study consists of 2 parts. In Part A, participants will receive investigational oral medication (active study drug) in tablet form. In Part B, participants will receive either active study drug or placebo for the first 16 weeks, followed by active study drug up to Week 52.  Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 66 weeks in each part, and involve about 22 visits to the study centre in Part A, and 18 visits in Part B.

Call the study centre near you, or register now.

Learn more about
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more